Basso Capital Management’s Eucrates Biomedical Acquisition Corp. Ordinary Shares EUCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-43,409
Closed -$430K 564
2022
Q2
$430K Hold
43,409
0.05% 361
2022
Q1
$427K Buy
43,409
+9,600
+28% +$94.4K 0.04% 367
2021
Q4
$330K Buy
33,809
+615
+2% +$6K 0.04% 314
2021
Q3
$325K Buy
+33,194
New +$325K 0.04% 282